Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Case Report of Sotalol Induced IgA Vasculitis

Author(s): Biniyam T. Mohammed*, Marwah Alchalabi, Anna Laskova, Chenyu Sun, Owais Lodhi, Yasmin Gerais and Ayah Galal Abdelrahman Alkhidir

Volume 19, Issue 1, 2023

Published on: 15 August, 2022

Page: [113 - 119] Pages: 7

DOI: 10.2174/1573397118666220623105703

Price: $65

Abstract

Background: IgA vasculitis is the most common form of systemic vasculitis in children but can occur in adults. Inciting antigens include infections, drugs, foods, insect bites, and immunizations. Antibiotics and tumor necrosis factor (TNF) alpha inhibitors are the most common class of drugs that cause IgA vasculitis. Although sotalol and rivaroxaban have been documented to cause leukocytoclastic vasculitis, we have never come across any literature attributing IgA vasculitis to either drug. Additionally, Rocky Mountain spotted fever has not been associated with IgA vasculitis despite being described in cutaneous and systemic vasculitis cases. Here, we present a case of IgA vasculitis triggered by sotalol with challenging differentials, including a recent infection with Rocky Mountain spotted fever, malignancy, and rivaroxaban as possible triggers.

Case Presentation: 68 yr old male with a history of lung cancer treated with resection and chemotherapy 5 years ago is currently in remission, and recently was started on sotalol and rivaroxaban for new-onset paroxysmal atrial fibrillation. He presented with diffuse petechial/purpural rash on the lower limbs, multiple joint pain, severe abdominal pain and rectal bleeds, hemoptysis, and renal dysfunction. IgG titers for RMSF were high. Punch biopsy of skin and renal biopsy were consistent with IgA vasculitis. Sotalol and rivaroxaban were stopped. The patient was treated with oral prednisone, and his condition relatively improved.

Conclusion: Ig A vasculitis is mostly a self-limiting disease, but adults tend to have a severe course. It is important to diagnose early and identify a trigger. Removing the offending agent or treating the underlying infection is an important aspect of management.

Keywords: Vasculitis, IgA, sotalol, RMSF, drug-induced, arthralgias.

« Previous Next »
Graphical Abstract

[1]
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65(1): 1-11.
[http://dx.doi.org/10.1002/art.37715] [PMID: 23045170]
[2]
Langford CA, Fauci AS. Harrison’s Principles of Internal Medicine. McGraw 2018.
[3]
Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch–Schönlein). Curr Opin Rheumatol 2013; 25(2): 171-8.
[http://dx.doi.org/10.1097/BOR.0b013e32835d8e2a] [PMID: 23318735]
[4]
Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: A population-based study. Rheumatology (Oxford) 2017; 56(8): 1358-66.
[http://dx.doi.org/10.1093/rheumatology/kex158] [PMID: 28444335]
[5]
Yagnik P, Jain A, Amponsah JK, et al. National trends in the epidemiology and resource use for Henoch-Schönlein Purpura (IgA vasculitis) hospitalizations in the United States from 2006 to 2014. Hosp Pediatr 2019; 9(11): 888-96.
[http://dx.doi.org/10.1542/hpeds.2019-0131] [PMID: 31575605]
[6]
Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA. Henoch-Schönlein purpura in adulthood and childhood. Two different expressions of the same syndrome. Arthritis Rheum 1997; 40(5): 859-64.
[http://dx.doi.org/10.1002/art.1780400513] [PMID: 9153547]
[7]
Hočevar A, Rotar Z, Ostrovršnik J, et al. Incidence of IgA vasculitis in the adult Slovenian population. Br J Dermatol 2014; 171(3): 524-7.
[http://dx.doi.org/10.1111/bjd.12946] [PMID: 24601900]
[8]
Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch–Schönlein purpura and comparison with outbreak of infectious diseases. Medicine (Baltimore) 2018; 97(36): e12217.
[http://dx.doi.org/10.1097/MD.0000000000012217] [PMID: 30200139]
[9]
Kao GF, Evancho CD, Ioffe O, Lowitt MH, Dumler JS. Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol 1997; 24(10): 604-10.
[http://dx.doi.org/10.1111/j.1600-0560.1997.tb01091.x] [PMID: 9449487]
[10]
Bal AK, Kairys SW. Kawasaki disease following Rocky Mountain spotted fever: A case report. J Med Case Reports 2009; 3(1): 7320.
[http://dx.doi.org/10.4076/1752-1947-3-7320] [PMID: 19830185]
[11]
Rasmussen C, Tisseyre M, Garon-Czmil J, et al. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev 2021; 20(1): 102707.
[http://dx.doi.org/10.1016/j.autrev.2020.102707] [PMID: 33197572]
[12]
Rustmann WC, Carpenter MT, Harmon C, Botti CF. Leukocytoclastic vasculitis associated with sotalol therapy. J Am Acad Dermatol 1998; 38(1): 111-2.
[http://dx.doi.org/10.1016/S0190-9622(98)70550-X] [PMID: 9448217]
[13]
Hasbal NB, Baştürk T, Koç Y, Sahutoğlu T, Bayrakdar Çağlayan F, Ünsal A. Leukocytoclastic vasculitis associated with a new anticoagulant: Rivaroxaban. Turk J Haematol 2017; 34(1): 116-7.
[http://dx.doi.org/10.4274/tjh.2016.0353] [PMID: 27796264]
[14]
Lee HL, Kim L, Kim CW, Kim JS, Nam HS, Ryu JS. Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism. Respir Med Case Rep 2019; 26: 219-22.
[http://dx.doi.org/10.1016/j.rmcr.2019.01.017] [PMID: 30740299]
[15]
Pelleg T, Kadakia RS, Siddiqui F, Biscardi F, Ie S. Sotalol induced diffuse alveolar hemorrhage. In: C43 Drug Induced Lung Disease: Case Reports. American Thoracic Society 2017; pp. A5569-9.
[16]
Rocky Mountain spotted fever data [Internet]. Illinois.gov. Available from: https://dph.illinois.gov/topics-services/diseases-and-conditions/diseases-a-z-list/rocky-mountain-spotted-fever/data.html [cited April 3, 2022].
[17]
Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States: A practical guide for health care and public health professionals. MMWR Recomm Rep 2016; 65(2): 1-44.
[http://dx.doi.org/10.15585/mmwr.rr6502a1] [PMID: 27172113]
[18]
Podjasek J, Wetter D, Pittelkow M, Wada D. Henoch-Schönlein purpura associated with solid-organ malignancies: Three case reports and a literature review. Acta Derm Venereol 2012; 92(4): 388-92.
[http://dx.doi.org/10.2340/00015555-1288] [PMID: 22293661]
[19]
Hankard A, Michot JM, Terrier B, et al. New insights on IgA vasculitis with underlying solid tumor: A nationwide French study of 30 patients. Clin Rheumatol 2021; 40(5): 1933-40.
[http://dx.doi.org/10.1007/s10067-020-05455-z] [PMID: 33099711]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy